Study of the Efficacy & Safety of IBI319 in Patients With Advanced

See also
Status	Clinical Trial	Phase
Completed	`NCT05082545` - Phase I Study of SHR-2002 + SHR-1316 in Patients With Advanced Malignant Tumors	Phase 1
Recruiting	`NCT04128085` - A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3804 in Subjects With Advanced Malignant Tumors	Phase 1
Recruiting	`NCT05229497` - A Phase Ib/II Study of AK112 in Combination With AK117 in Advanced Malignant Tumors	Phase 1/Phase 2
Recruiting	`NCT06223841` - A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors	Phase 1/Phase 2
Not yet recruiting	`NCT05728541` - Dose Escalation and Expansion Study of SYH2043 in Patients With Advanced Malignant Tumors	Phase 1
Recruiting	`NCT05354076` - Study on the Correlation Between Immunoglobulin and Liposomal Doxorubicin in Vivo	Phase 2
Recruiting	`NCT05868876` - A Phase Ia/Ib Open Label，Clinical Study Evaluating the Safety, Tolerability and Preliminary Efficacy of AK127 in Combination With AK104 in Patients With Advanced Malignant Tumors	Phase 1
Recruiting	`NCT05991583` - A Clinical Trial to Evaluate Effect of IBB0979 in Patients With Advanced Malignant Tumors	Phase 1/Phase 2
Recruiting	`NCT05396391` - A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors	Phase 1/Phase 2
Recruiting	`NCT05235542` - A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors	Phase 1/Phase 2
Recruiting	`NCT05110807` - A Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB3617 Capsule in Patients With Advanced Malignant Tumors	Phase 1
Recruiting	`NCT05214482` - A Study of AK112 in Advanced Malignant Tumors	Phase 1/Phase 2
Not yet recruiting	`NCT05653284` - A Study of AK130 in Patients With Advanced Malignant Tumors	Phase 1
Recruiting	`NCT05223231` - Evaluation of LBL-019 Monotherapy or Combined With Anti-PD-1 Antibody in the Treatment of Advanced Malignant Tumors	Phase 1/Phase 2
Enrolling by invitation	`NCT05198817` - A Trial of SHR-2002 Injection or Combined With Other Anti-cancer Medication in Advanced Malignant Tumors of Patients	Phase 1
Active, not recruiting	`NCT05193721` - A Clinical Study of the Safety and Tolerability of SHR-1901 in Subjects With Advanced Malignant Tumors	Phase 1
Not yet recruiting	`NCT06226363` - Phase I Study of LNF1901 in Advanced Malignant Tumors	Phase 1
Recruiting	`NCT06167486` - SG2918 For Advanced Malignant Tumors	Phase 1
Recruiting	`NCT04980690` - Clinical Trial of IBC0966 in Patients With Advanced Malignant Tumors	Phase 1/Phase 2
Recruiting	`NCT05877924` - A Study of NBL-020 Injection in Subjects With Advanced Malignant Tumors.	Phase 1

NCT number	NCT04708210
Study type	Interventional
Source	Innovent Biologics (Suzhou) Co. Ltd.
Contact
Status	Active, not recruiting
Phase	Phase 1
Start date	April 28, 2021
Completion date	June 21, 2023

Study of the Efficacy and Safety of IBI319 in Patients With Advanced Malignant Tumors

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms